EUVIMEDEUVIMED entdecken
Open Access

Role of the xenobiotic-activated pregnane X receptor in type 1 and type 2 diabetes in male mice

Daniel Okwudili Nnamani, Sora Choi, Malvin Ofosu-Boateng, Lidya H Gebreyesus, Elizabeth Twum, Marianne Polunas, Michael Goedken, Nour Yadak, Samuel Dagogo-Jack, Rexford S Ahima, Susan T Yeyeodu, Frank J Gonzalez und 1 weitere

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2025.117482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Daniel Okwudili Nnamani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Pregnane X Receptor, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Receptors, Steroid. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIMHD NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnane X receptor (PXR) primarily regulates enzymes that detoxify xenobiotics and therapeutic drugs, but its surprising role in diabetes has recently emerged. In this study we treated male wild-type (WT) and Pxr-null (PXR-KO) mice for 14 weeks with control or obesity- and type 2 diabetes-promoting high-fat diet (HFD), followed by a single dose of vehicle or 100 mg/kg of the pancreatic beta cell-specific toxin streptozotocin (STZ) and two more weeks of their respective diets. Mice were evaluated for hyperglycemia and serum and tissue markers of metabolic syndrome to characterize potential PXR modulation of type 1 (T1DM, STZ + control diet) and type 2 diabetes mellitus (T2DM, STZ + HFD). In the WT but not PXR-KO mouse T1DM and T2DM models, we observed hyperglycemia, reduced insulin levels, weight loss, pancreatic beta-cell destruction, elevated phosphoenolpyruvate carboxykinase 1, reduced glucokinase and liver fatty acid binding protein 1, and lower fibroblast growth factor 21 mRNA. In WT but not PXR-KO T2DM model mice, farnesoid X receptor mRNA was decreased, while glucose 6-phosphatase mRNA, cholesterol-7a-hydroxylase (CYP7A1) and cytochrome P450 2E1 proteins, serum liver injury markers, hepatic triglycerides and non-esterified fatty acids were increased. HFD-fed WT mice developed obesity, dyslipidemia, hyperinsulinemia, hepatotoxicity, and lipogenesis but not PXR-KO mice. In contrast, T2DM PXR-KO mice showed elevated glucose transporters (GLUT1, 2, and 4) and phosphorylated-adenosine monophosphate-activated protein kinase α (p-AMPKα) proteins associated with reduced hyperglycemia and lipogenesis. These data revealed that PXR contribute to STZ-induced pathologies, identifying this receptor as a potential therapeutic target for the prevention and treatment of diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnane X ReceptorDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Receptors, SteroidDiabetes Mellitus, ExperimentalXenobioticsAnimalsMaleMiceMice, KnockoutMice, Inbred C57BLDiet, High-Fat

Stichwörter der Autor:innen

DiabetesHigh-fat dietObesityPXRPancreatic isletStreptozotocin

Substanzen

Pregnane X ReceptorReceptors, SteroidXenobiotics

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 881 Madison Avenue, Memphis, TN 38163, USA.
  • The Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.
  • Office of Research and Economic Development, Research Pathology Services, Rutgers University, Piscataway, NJ, USA.
  • Department of Pathology and Laboratory Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, 920 Madison Avenue, Memphis, TN 38163 USA.
  • Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins University School of Medicine, 333 East Monument Street, Baltimore, MD 21205, USA.

Förderung

  • NIAAA NIH HHS
  • NIMHD NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • U.S. Department of Health and Human Services
  • Health Science Center, University of Tennessee
  • National Institutes of Health
  • National Institute on Minority Health and Health Disparities

Zitieren

APA

Nnamani, D. O., Choi, S., Ofosu-Boateng, M., Gebreyesus, L. H., Twum, E., Polunas, M., Goedken, M., Yadak, N., Dagogo-Jack, S., Ahima, R. S., Yeyeodu, S. T., Gonzalez, F. J., & Gyamfi, M. A. (2026). Role of the xenobiotic-activated pregnane X receptor in type 1 and type 2 diabetes in male mice. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117482

Vancouver

Nnamani DO, Choi S, Ofosu-Boateng M, Gebreyesus LH, Twum E, Polunas M, et al. Role of the xenobiotic-activated pregnane X receptor in type 1 and type 2 diabetes in male mice. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117482

BibTeX
@article{Nnamani2026,
  author = {Nnamani, Daniel Okwudili and Choi, Sora and Ofosu-Boateng, Malvin and Gebreyesus, Lidya H and Twum, Elizabeth and Polunas, Marianne and Goedken, Michael and Yadak, Nour and Dagogo-Jack, Samuel and Ahima, Rexford S and Yeyeodu, Susan T and Gonzalez, Frank J and Gyamfi, Maxwell A},
  title = {Role of the xenobiotic-activated pregnane X receptor in type 1 and type 2 diabetes in male mice},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2025.117482}
}
Kostenlos starten →